List of Palatin Technologies patents

Patents where

Current Assignee

Name

Palatin Technologies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7351690 Knockout identification of target-specific sites in peptides	Patent 7351690 was granted and assigned to Palatin Technologies on April, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7351690	April 1, 2008
‌ US Patent 11286280 Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy	Patent 11286280 was granted and assigned to Palatin Technologies on March, 2022 by the United States Patent and Trademark Office.	Palatin Technologies	Palatin Technologies	United States Patent and Trademark Office	11286280	March 29, 2022
‌ US Patent 7307063 Melanocortin metallopeptides for treatment of sexual dysfunction	Patent 7307063 was granted and assigned to Palatin Technologies on December, 2007 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7307063	December 11, 2007
‌ US Patent 7097824 Tuftsin metallopeptide analogs and uses thereof	Patent 7097824 was granted and assigned to Palatin Technologies on August, 2006 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7097824	August 29, 2006
‌ US Patent 7396814 Metallopeptide compositions for treatment of sexual dysfunction	Patent 7396814 was granted and assigned to Palatin Technologies on July, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7396814	July 8, 2008
‌ US Patent 7176279 Cyclic peptide compositions and methods for treatment of sexual dysfunction	Patent 7176279 was granted and assigned to Palatin Technologies on February, 2007 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7176279	February 13, 2007
‌ US Patent 7417027 Linear and cyclic melanocortin receptor-specific peptides	Patent 7417027 was granted and assigned to Palatin Technologies on August, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7417027	August 26, 2008
‌ US Patent 11590209 Use of bremelanotide in patients with controlled hypertension	Patent 11590209 was granted and assigned to Palatin Technologies on February, 2023 by the United States Patent and Trademark Office.	Palatin Technologies	Palatin Technologies	United States Patent and Trademark Office	11590209	February 28, 2023
‌ US Patent 7795221 Linear natriuretic peptide constructs	Patent 7795221 was granted and assigned to Palatin Technologies on September, 2010 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7795221	September 14, 2010
‌ US Patent 7345144 Cyclic peptides for treatment of cachexia	Patent 7345144 was granted and assigned to Palatin Technologies on March, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7345144	March 18, 2008
‌ US Patent 7342089 Cyclic peptides for treatment for cachexia	Patent 7342089 was granted and assigned to Palatin Technologies on March, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7342089	March 11, 2008
‌ US Patent 7732451 Naphthalene-containing melanocortin receptor-specific small molecule	Patent 7732451 was granted and assigned to Palatin Technologies on June, 2010 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7732451	June 8, 2010
‌ US Patent 7968548 Melanocortin receptor-specific piperazine compounds with diamine groups	Patent 7968548 was granted and assigned to Palatin Technologies on June, 2011 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7968548	June 28, 2011
‌ US Patent 7964601 Melanocortin receptor-specific compounds	Patent 7964601 was granted and assigned to Palatin Technologies on June, 2011 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7964601	June 21, 2011
‌ US Patent 7727991 Substituted melanocortin receptor-specific single acyl piperazine compounds	Patent 7727991 was granted and assigned to Palatin Technologies on June, 2010 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7727991	June 1, 2010
‌ US Patent 7727990 Melanocortin receptor-specific piperazine and keto-piperazine compounds	Patent 7727990 was granted and assigned to Palatin Technologies on June, 2010 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7727990	June 1, 2010
‌ US Patent 8933194 Melanocortin-1 receptor-specific linear peptides	Patent 8933194 was granted and assigned to Palatin Technologies on January, 2015 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	8933194	January 13, 2015
‌ US Patent 7354923 Piperazine melanocortin-specific compounds	Patent 7354923 was granted and assigned to Palatin Technologies on April, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7354923	April 8, 2008
‌ US Patent 9458201 Melanocortin receptor-specific heptapeptides	Patent 9458201 was granted and assigned to Palatin Technologies on October, 2016 by the United States Patent and Trademark Office.	Palatin Technologies	Palatin Technologies	United States Patent and Trademark Office	9458201	October 4, 2016
‌ US Patent 8247530 N-alkylated cyclic peptide melanocortin agonists	Patent 8247530 was granted and assigned to Palatin Technologies on August, 2012 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	8247530	August 21, 2012
‌ US Patent 8729224 Melanocortin receptor-specific peptides for treatment of female sexual dysfunction	Patent 8729224 was granted and assigned to Palatin Technologies on May, 2014 by the United States Patent and Trademark Office.	Palatin Technologies	Palatin Technologies	United States Patent and Trademark Office	8729224	May 20, 2014
‌ US Patent 7456184 Melanocortin receptor-specific compounds	Patent 7456184 was granted and assigned to Palatin Technologies on November, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7456184	November 25, 2008
‌ US Patent 7601753 Pyrrolidine melanocortin-specific compounds	Patent 7601753 was granted and assigned to Palatin Technologies on October, 2009 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7601753	October 13, 2009
‌ US Patent 7189755 Pyrrolidine melanocortin-specific compounds	Patent 7189755 was granted and assigned to Palatin Technologies on March, 2007 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7189755	March 13, 2007
‌ US Patent 7326707 Bicyclic melanocortin-specific compounds	Patent 7326707 was granted and assigned to Palatin Technologies on February, 2008 by the United States Patent and Trademark Office.		Palatin Technologies	United States Patent and Trademark Office	7326707	February 5, 2008

Results per page:

63 results

0 selected

63 results

0 selected